Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Sell
8,040
-16
-0.2% -$5.48K 0.08% 108
2026
Q1
$2.83M Buy
8,056
+21
+0.3% +$7.49K 0.09% 102
2025
Q4
$2.63M Buy
8,035
+37
+0.5% +$11.7K 0.09% 106
2025
Q3
$2.26M Buy
7,998
+1,800
+29% +$522K 0.08% 114
2025
Q2
$1.73M Buy
6,198
+149
+2% +$42.2K 0.07% 119
2025
Q1
$1.88M Hold
6,049
0.09% 110
2024
Q4
$1.58M Hold
6,049
0.07% 113
2024
Q3
$1.95M Sell
6,049
-306
-5% -$100K 0.09% 99
2024
Q2
$1.99M Hold
6,355
0.1% 93
2024
Q1
$1.81M Buy
6,355
+1,691
+36% +$495K 0.1% 94
2023
Q4
$1.34M Buy
4,664
+73
+2% +$19.9K 0.08% 103
2023
Q3
$1.23M Hold
4,591
0.08% 98
2023
Q2
$1.02M Buy
4,591
+49
+1% +$11.4K 0.07% 120
2023
Q1
$1.1M Hold
4,542
0.08% 110
2022
Q4
$1.19M Hold
4,542
0.09% 94
2022
Q3
$1.02M Buy
4,542
+1,010
+29% +$245K 0.09% 103
2022
Q2
$859K Hold
3,532
0.07% 112
2022
Q1
$890K Sell
3,532
-14
-0.4% -$3.22K 0.07% 121
2021
Q4
$798K Sell
3,546
-6
-0.2% -$1.27K 0.05% 143
2021
Q3
$755K Buy
3,552
+11
+0.3% +$2.53K 0.06% 142
2021
Q2
$863K Buy
3,541
+184
+5% +$45.3K 0.07% 120
2021
Q1
$835K Hold
3,357
0.07% 112
2020
Q4
$772K Sell
3,357
-130
-4% -$30K 0.08% 107
2020
Q3
$886K Buy
3,487
+91
+3% +$22.5K 0.12% 85
2020
Q2
$801K Buy
3,396
+47
+1% +$10.7K 0.11% 84
2020
Q1
$679K Buy
3,349
+26
+0.8% +$5.68K 0.12% 79
2019
Q4
$801K Hold
3,323
0.11% 89
2019
Q3
$643K Sell
3,323
-17
-0.5% -$3.26K 0.09% 96
2019
Q2
$615K Sell
3,340
-67
-2% -$12K 0.09% 106
2019
Q1
$647K Sell
3,407
-25
-0.7% -$4.77K 0.09% 114
2018
Q4
$688K Buy
3,432
+111
+3% +$21.7K 0.11% 105
2018
Q3
$688K Hold
3,321
0.11% 95
2018
Q2
$613K Sell
3,321
-500
-13% -$88.4K 0.1% 100
2018
Q1
$651K Buy
3,821
+443
+13% +$81.3K 0.11% 96
2017
Q4
$587K Hold
3,378
0.1% 100
2017
Q3
$630K Buy
3,378
+400
+13% +$70.9K 0.12% 90
2017
Q2
$513K Sell
2,978
-150
-5% -$24.4K 0.1% 95
2017
Q1
$513K Sell
3,128
-43
-1% -$7.14K 0.1% 90
2016
Q4
$464K Sell
3,171
-218
-6% -$32.8K 0.09% 91
2016
Q3
$565K Sell
3,389
-99
-3% -$16.7K 0.12% 80
2016
Q2
$531K Sell
3,488
-956
-22% -$149K 0.11% 80
2016
Q1
$666K Buy
4,444
+2
+0% +$297 0.15% 69
2015
Q4
$721K Buy
4,442
+373
+9% +$58.6K 0.18% 62
2015
Q3
$563K Buy
4,069
+46
+1% +$7.25K 0.15% 65
2015
Q2
$618K Buy
4,023
+8
+0.2% +$1.28K 0.16% 70
2015
Q1
$642K Buy
4,015
+1,379
+52% +$217K 0.16% 67
2014
Q4
$420K Buy
2,636
+1
+0% +$156 0.11% 85
2014
Q3
$370K Buy
2,635
+150
+6% +$19.6K 0.11% 78
2014
Q2
$294K Buy
2,485
+686
+38% +$79.4K 0.09% 97
2014
Q1
$222K Buy
1,799
+1
+0.1% +$121 0.07% 110
2013
Q4
$205K Hold
1,798
0.07% 109
2013
Q3
$201K Buy
1,798
+806
+81% +$87.4K 0.08% 104
2013
Q2
$98K Buy
+992
New +$103K 0.05% 148

Other funds holding AMGN

Joel Isaacson & Co's AMGN Position: Q2 2026 in Review

Joel Isaacson & Co reduced its Amgen (AMGN) stake by 0.2% in Q2 2026, selling an estimated $5.48K and leaving 8,040 shares worth $2.91M. The position accounts for 0.08% of the portfolio, ranked #108.

Joel Isaacson & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Joel Isaacson & Co held 8,040 shares of Amgen worth $2.91M as of Q2 2026.
  • Joel Isaacson & Co sold 16 Amgen shares in Q2 2026, an estimated $5.48K.
  • Amgen made up 0.08% of Joel Isaacson & Co's portfolio in Q2 2026, its #108 holding.
  • Joel Isaacson & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.